fbpx
QQQ
+ 0.00
324.13
+ 0%
DIA
+ 0.00
319.49
+ 0%
SPY
+ 0.00
391.84
+ 0%
TLT
+ 0.00
140.84
+ 0%
GLD
+ 0.00
168.98
+ 0%

Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest EPS Growth Forecast For Next 5 Years

by
September 14, 2015 4:53 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of EPS growth forecast for the next five years.

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) earnings per share growth forecast for the next five years is 46.09 percent. Alnylam Pharmaceuticals’ trailing-twelve-month revenue is $62.20 million.

Dyax Corp. (NASDAQ: DYAX) EPS growth forecast for the next five years is 30.70 percent. Dyax’s trailing-twelve-month gross margin is 87.10 percent.

Insys Therapeutics Inc (NASDAQ: INSY) EPS growth forecast for the next five years is 28.00 percent. Insys Therapeutics’ PEG ratio is 2.64.

China Biologic Products Inc (NASDAQ: CBPO) earnings per share growth forecast for the next five years is 25.41 percent. China Biologic Products’ trailing-twelve-month ROE is 32.90 percent.

Posted-In:

Trading Ideas

Related Articles

Stocks That Hit 52-Week Highs On Tuesday

    This morning 163 companies set new 52-week highs. read more

Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 285 companies set new 52-week highs. read more

Alnylam Shares Resume Trading; Up ~8%

Alnylam Shares Halted; News Pending